ABBOTT LABORATORIES·4

Jul 23, 5:04 PM ET

PEDERSON MICHAEL J 4

4 · ABBOTT LABORATORIES · Filed Jul 23, 2020

Insider Transaction Report

Form 4
Period: 2020-07-21
PEDERSON MICHAEL J
Senior Vice President
Transactions
  • Sale

    Common shares without par value

    2020-07-21$98.00/sh23,008$2,254,78473,891 total
  • Exercise/Conversion

    Common shares without par value

    2020-07-21+23,00896,899 total
  • Tax Payment

    Common shares without par value

    2020-07-21$99.08/sh2,437$241,45871,454 total
  • Exercise/Conversion

    Option (right to buy)

    2020-07-2123,00823,008 total
    Exercise: $50.72From: 2019-07-21Exp: 2027-07-20Common shares (23,008 underlying)
Footnotes (1)
  • [F1]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -